Skip to content
Adrienne Monson – Lifestyle
Author:
Keros Therapeutics, Inc.
Keros Therapeutics Appoints Anne Prener to its Board of Directors
June 25, 2026
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
June 1, 2026
Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
May 14, 2026
Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS
March 9, 2026
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference
March 9, 2026